Federal award
ACELRX PHARMACEUTICALS, INC.
W81XWH15C0046
Contract
Obligated and Ceiling
- Obligated (net)
- $17,012,744.49
- Ceiling (potential value, not spending)
- $19,252,744.49
- Current value
- $17,012,744.49
- Gross positive obligations
- $20,502,744.49
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ACELRX PHARMACEUTICALS, INC. · RS3UJNCL6YG1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ACELRX PHARMACEUTICALS, INC. · RS3UJNCL6YG1
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81XWH15C0046
- Award type code
- D
- Actions
- 9 · May 11, 2015 to Feb 28, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 28, 2018 | FY2018 | P00008 | B | $0.00 | — |
| Mar 9, 2017 | FY2017 | P00007 | B | $0.00 | — |
| Jun 14, 2016 | FY2016 | P00006 | C | $4,365,695.49 | — |
| Mar 2, 2016 | FY2016 | P00005 | B | $0.00 | — |
| Jan 29, 2016 | FY2016 | P00004 | B | $0.00 | — |
| Sep 4, 2015 | FY2015 | P00003 | C | $5,154,049.00 | — |
| Sep 1, 2015 | FY2015 | P00002 | M | $0.00 | — |
| Aug 6, 2015 | FY2015 | P00001 | M | −$3,490,000.00 | — |
| May 11, 2015 | FY2015 | 0 | — | $10,983,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.